Common name: Fufang Biejia Ruangan Tablets
Product Name: Furui
Ingredients: Angelica (system), Curcuma, Radix Angelicae, Angelica, Panax Notoginseng, Codonopsis, Astragalus, Ziheche, Cordyceps, Banlangen, Forsythia.
Properties: This product is brown to tan flakes; slightly bitter.
Indications: Soft and firm disperse, dissolve blood stasis and detoxify, nourish qi and nourish blood. It is used for chronic hepatitis B liver fibrosis, and early liver cirrhosis is due to blood stasis, blood deficiency and heat toxicity. Symptoms: Faint pain in the ribs or subcostal lumps, dull complexion, full stomach bulge, poor appetite, fatigue, dry mouth, bitterness, red silk, etc.
Dosage: Orally. 4 tablets at a time, 3 times a day, 6 months as a course of treatment, or as directed by a doctor.
Adverse reactions: Occasionally a mild gastrointestinal reaction can usually relieve itself.
Contraindications: Banned for pregnant women.
Note: Not clear yet
Drug Interactions: Drug interactions may occur if used concurrently with other drugs, please consult your physician or pharmacist for details.
Pharmacology and toxicology: 1. Pharmacological effects: The experimental results of animal liver fibrosis model treatment show that it has a significant blocking effect on early liver fibrosis, and can inhibit the proliferation of fat storage cells, reduce collagen synthesis and reduce collagen in the Disse cavity Excessive deposition, dissolution and absorption of liver fibrosis that has formed can also effectively inhibit the expression of α2 (I) mRNA in liver fibrosis. Experiments have also shown that phagocytic function of mouse peritoneal macrophages is enhanced.
2. Toxicology study: Acute toxicity test. Mice were administered orally twice a day according to the maximum tolerated amount. No acute toxicity was observed in the mice. After long-term toxicity experiments, rats were intragastrically administered for 6 months without significant toxicity and adverse reactions.
Clinical research: This product was approved by the Pharmacy Administration of the Ministry of Health in 1997 for 420 clinical trials.
Validity: 24 months
Approval number: National Drug Standard Z19991011
Company Name: Inner Mongolia Furui Medical Technology Co., Ltd.